Trevi Therapeutics, Inc. (TRVI) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $12.0K | -65.7% |
| 2024 | $35.0K | -74.5% |
| 2023 | $137.0K | -13.8% |
| 2022 | $159.0K | — |
| 2020 | $32.0K | +255.6% |
| 2019 | $9.0K | -94.3% |
| 2018 | $158.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $12.0K | -65.7% |
| 2024 | $35.0K | -74.5% |
| 2023 | $137.0K | -13.8% |
| 2022 | $159.0K | — |
| 2020 | $32.0K | +255.6% |
| 2019 | $9.0K | -94.3% |
| 2018 | $158.0K | — |